Mithra and Farmitalia Announce Commercial Launch of Myring™ in Italy,
the Fourth Largest Market in the World
• Successful launch of Mithra’s hormonal contraceptive ring in Italy under the trademark
Kirkos®
• Italy is the third largest European market and the fourthworldwide, with 2 million vaginal rings
sold per year
• Mithra CDMO pursues the manufacturing of its Myring™ orders for new commercial launches
planned for 2021
Liege, Belgium, 2 March 2021 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated
to Women’s Health, today announces the commercial launch of its vaginal contraceptive ring Myring™
in Italy.
Italy is the fourth largest worldwide contraceptive rings market in terms of sales value and volume,
after the United States, Germany and Spain. With 2 million vaginal rings sold per year, the Italian
contraceptive rings market is worth EUR 22 million per year with an average growth of 3% per year1
.
Mithra’s vaginal contraceptive ring will be distributed in Italy under the brand name Kirkos® by
Farmitalia.
In Europe, the extension of the shelf life of Myring™ to 36 months, the removal of the requirement for
special temperature storage and the 6-pack format offer distributors, pharmacists and patients a more
convenient and economic option compared to competitor products.
Fabio Scaccia, CEO Farmitalia, commented: “The launch of a first class vaginal contraceptive ring gives
us a very good chance to establish a fruitful cooperation with Mithra and to strengthen our offer of selected
products in Gynaecology where we are among the leader companies into the Italian market. We are excited
and fully committed in the launch of Kirkos® and we do strongly believe it will be a great success”.
Leon Van Rompay, CEO Mithra Women’s Health, commented: “ We are pleased to launch our Myring™ in
Italy where the vaginal ring is a very popular contraceptive option for women. After the successful launch
last year in the first European market, Germany, we are now present on the third largest market in Europe,
but also the fourth in the world. In addition to the seven European countries already covered, further
commercial launches should follow this year in Europe and the rest of the world. Our Mithra CDMO has
managed to maintain its manufacturing forecasts since the beginning of the Covid-19 crisis and will
continue its dynamics this year in order to meet expected commercial launches.”